Intensity Therapeutics is a Qualified Connecticut Businesses
Intensity Therapeutics' is a "Qualified Connecticut Business" (QCB) as approved by CT Innovations. The State of Connecticut launched a program in 2010 that allows Angels providing capital to QCBs to take a credit against Connecticut State income tax for certain investments made in qualifying businesses. Investments must be at least $25,000 in order to be considered under the Program and the income tax credit equals 25% of the cash investment up to a maximum credit of $250,000.
Intensity Therapeutics is a preclinical stage company that has conducted proof-of-concept in vivo experiments using its novel in situ chemovaccination technology. The Company is interested in collaborating with pharmaceutical, imaging or biotechnology companies interested in developing the new approach to treating cancer.
Who we are
Intensity Therapeutics is a preclinical, in vivo stage Company interested in helping to advance the Company’s novel in situ chemovaccination technology and products.